Antipsychotic,Drugs,Market,201 marketing Antipsychotic Drugs Market 2016: Global Industry Review, Res

Automation technologies represent a fundamental aspect of any modern industry. The major types of industrial automation solutions, such as DCS, PLC, SCADA, and MES, are used on a large-scale in process and discrete industries.DCS technologie Awhile ago, I got an email from one of the "gurus" I follow and it shocked me. The gist of it was this person wanted to trade services for a household item.To say it floored me would be an understatement.What was worse was a few days later t

Antipsychotic drugs are also termed as major tranquilizers or neuroleptics and these are primarily used to treat psychosis. The common psychotic disorders, where these drugs are majorly used include schizophrenia, hallucinations, delusions, bipolar disorder and others. The antipsychotic drugs market is expected to grow due to the rising number of Schizophrenic patients. However, patent expiration of major brands could negatively impact the market growth. Deep-dive analysis of global antipsychotic drugs market focuses on major market dynamics such as drivers, restrains and opportunities. Competitive landscape section profiles the key players on the basis of business performance, strategic moves and SWOT analysis. Profound analysis of segments would be helpful to understand the product distribution trends in each segment within the global antipsychotic drugs market.High prevalence of Schizophrenia and psychotic disorders are the prime drivers for global antipsychotic drugs market. Increased drug abuse, over prescription of drugs and addiction to antipsychotic drugs are the additional factors that drive the market growth for antipsychotic drugs. However, patent expiry of major brands over the past few years had negative impact on market growth and it has been responsible to the rising competition from generic drug manufacturer. Serious side effects such as tardive dyskinesia, associated with antipsychotics also restraints the market growth. Emerging economies are the opportunistic markets for antipsychotics due to large pool of aging population, which has high risk of psychosis, and increased healthcare awareness.Request a Brochure of This Report, here: http://www.marketresearchstore.com/report/world-antipsychotic-drugs-market-opportunities-and-forecasts-68521#RequestSampleGlobal Antipsychotic Drugs Market by BrandsThe global antipsychotic drugs market is segmented into three categories based on brands such as First, Second and Third generation antipsychotic drugs. Except Halodol and lithium carbonate, all first generation antipsychotic agents are called as standard or typical antipsychotics, as they act similar i.e., interference with neurotransmitters. Second generation antipsychotics are also known as atypical antipsychotic agents and act as broad-spectrum antagonists of dopamine, serotonin and alpha-noradrenergic receptors. With development of technology and growing competition to gain largest market share, researchers are focusing on first generation antipsychotics to better understand their working mechanism. Abilify and Seroquel are topmost marketed brands due their high therapeutic efficacy and reduced side effects.Global Antipsychotic Drugs Market by ApplicationThe global antipsychotic drugs are used to treat different brain disorders such as Schizophrenia, Bipolar disorder, Dementia, Unipolar Depression and Others. The drugs used in Schizophrenia and psychotic depression are expected to boost the growth of antipsychotic drugs market due to increasing incidences of these two conditions.Global Antipsychotic Drugs Market by GeographyGeographically, global antipsychotic drugs market is segmented into North America, Europe, Asia-Pacific and LAMEA. Antipsychotics are the largely prescribed drugs in the North American region due to large patient pool suffering from mental and psychotic disorders. Asia-Pacific and LAMEA are the lucrative market for global antipsychotic drugs manufacturers, due to large patient pool and rising healthcare awareness.Competitive LandscapeThe key players within global antipsychotic drugs market include Eli Lilly, AstraZeneca, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline and Johnson & Johnson. Patent expiration of major brands such as Zyprexa (by Eli Lilly) and Seroquel (by AstraZeneca) has negatively impacted the total revenue of this maket. Generic competition is soaring due to patent expiration of six largest antipsychotic drugs in 2012.Buy This Premium Report: http://www.marketresearchstore.com/report/world-antipsychotic-drugs-market-opportunities-and-forecasts-68521#InquiryForBuyingHigh Level Analysis The comprehensive analysis of global antipsychotic drugs market provides an overview of the market and its key concerns. Market segmentation is concentric towards product distribution trends of each segment that would be helpful to strategist in deciding on the market segments. Market dynamics covers market drivers, restrains and opportunities, which would help to understand the market behaviour. Porter’s Five Forces analysis would be helpful in determining the market profitability. Buyers bargaining power is high for global antipsychotic drugs market due to patent expiration of major brands and availability of many generic medicines in the marketplace. Global antipsychotic drugs market has high threat from new entrants as major brands have lost their patent protection in 2012. Industrial rivalry is intense due to entry of numerous generic competitors, which forces big players to manipulate their drug prices according to changing market trends.KEY BENEFITSThis report offers the following benefits in particular:• Complete analysis of drivers, restrains and opportunities within global antipsychotic drugs market would assist professionals to understand the market behavior • Profound assessment of geography focuses on niche market areas and provides forward looking perspective • Porter’s Five Forces framework would assist strategist in decision making by analyzing the market profitability within global antipsychotic drugs market • Comprehensive assessment of key leaders and their market strategies for global antipsychotic drugs market would be informative to professionals in the corporate sectorKEY DELIVERABLES• The global antipsychotic drugs market is segmented into two major categories such as technology and geography.MARKET BY BRANDS First Generation Drugs (Standard / Typical Antipsychotic Agents)• Thorazine (Chlorpromazine HCl) • Serentil (Mesoridazine Besylate) • Mellaril (Thioridazine HCl) • Haldol (Haloperidol) • Loxitane (Loxapine Succinate) • Trilafon (Perphenazine) • Navane (Thiothixene) • Sordinol (Clopenthixol) • OthersSecond generation Drugs (Atypical Antipsychotic Agents)• Zyprexa (Olanzapine) • Geodon (Ziprasidone) • Seroquel (Quetiapine) • Risperdal (Risperidone) • Clozaril (Clozapine) • Invega (Paliperidone) • Asendin (Amoxapine) • Latuda (Lurasidone) • Others • Third generation Drugs • Abilify (Aripiprazole)MARKET BY APPLICATION• Schizophrenia • Bipolar Disorder • Dementia • Unipolar Depression • OtherMARKET BY GEOGRAPHY• North AmericaAbout Market research StoreMarket Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.Contact Us:Joel John 3422 SW 15 Street, Suit #8138, Deerfield Beach, Florida 33442, USA USA Tel: +1-386-310-3803 GMT Tel: +49-322 210 92714 USA/Canada Toll Free No.1-855-465-4651 Email: [email protected] Web: http://www.marketresearchstore.com/